BBruno Sarmento is Principal Investigator and Group Leader at Institute for Research and Innovation in Health (i3S), University of Porto (UP), and Invited Associate Professor at Instituto Universitário de Ciências da Saúde (IUCS), Portugal. His research is focused on the development of mucosal tissue engineering models to validate functionalized nanomedicines and to perform in vitro/in vivo correlation. He has also established functionalized nanomedicines for mucosal drug delivery of drug with poor mucosal bioavailability. He published more than 400 papers in international journals, most in top journals (20000 Scopus citations; H-index 73). He edited 5 books, participated in more than 50 invited/selected talks in national and international meetings and was awarded several distinctions. He has supervised/co-supervised 15 Post-Docs, 50 PhD students and 40 MSc students. He is editor of European Journal of Pharmaceutical Sciences, and member of the Editorial Advisory Board of several international journals, including the Journal of Controlled Release, Expert Opinion on Drug Delivery and Pharmaceutics. Bruno Sarmento was the first Chair of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society (CRS) and is now Director-at-Large of CRS and member of CRS College of Fellows.
This book intends to be an updated compilation of the most important buccal, gastric, intestinal, pulmonary, nasal, vaginal, ocular, skin and blood-brain barrier in vitro models for predicting the permeability of drugs. Concepts and Models for Drug Permeability Studies focuses on different approaches and comprises of various models. Each model describes the protocol of seeding and conservation, the application for specific drugs, and takes into account the maintenance of physiologic characteristics and functionality of epithelium, from the simplest immortalized cell-based monoculture to the most complex engineered-tissue models. Chapters also discuss the equivalence between in vitro cell and tissue models and in vivo conditions, highlighting how each model may provisionally resemble a different drug absorption route. - Updated information regarding the most recent in vitro models to study the permeability of drugs- Short and concise chapters covering all the biological barriers with interest in drug permeability- A combination of bibliographic information related with individual models and footnote instructions of technical procedures for construction of cell and tissue-based models- Simple and clear scientific content, adaptable for young scientists and experimented researchers
List of contributors
João Albuquerque, University of Porto, Porto, Portugal
Isabel Almeida, University of Porto, Porto, Portugal
Fernanda Andrade
Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal
Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain
Francisca Araújo
Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
Marival Bermejo Sanz, Universidad Miguel Hernández, San Juan de Alicante, Alicante, España
Malgorzata Burek, Department of Anaesthesia and Critical Care, University of Wurzburg, Wurzburg, Germany
Miguel Ángel Cabrera Pérez
Universidad Central Marta Abreu de Las Villas, Santa Clara, Villa Clara, Cuba
Universidad Miguel Hernández, San Juan de Alicante, Alicante, España
Pedro Castro, CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Porto, Portugal
Luise Chaves, UCIBIO/REQUIMTE—Laboratory of Applied Chemistry, University of Porto, Porto, Portugal
João Coentro
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Faculdade de Engenharia da Universidade do Porto (FEUP), Porto, Portugal
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal
Ana Costa
Instituto de Engenharia Biomédica (INEB), University of Porto, Porto, Portugal
CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra PRD, Portugal
Joana Costa
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
FEUP—Faculdade de Engenharia da Universidade do Porto, Porto, Portugal
Paulo Costa, University of Porto, Porto, Portugal
Sara Baptista da Silva
Faculty of Pharmacy, University of Porto, Porto, Portugal
CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Porto, Portugal
José das Neves
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Tiago dos Santos, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Domingos Ferreira, Faculty of Pharmacy, University of Porto, Porto, Portugal
Carola Y. Förster, Department of Anaesthesia and Critical Care, University of Wurzburg, Wurzburg, Germany
Isabel González Álvarez, Universidad Miguel Hernández, San Juan de Alicante, Alicante, España
Marta González-Álvarez, Universidad Miguel Hernández, San Juan de Alicante, Alicante, España
Luís Gouveia, iMed.UL, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Pedro L. Granja
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Faculdade de Engenharia da Universidade do Porto (FEUP), Porto, Portugal
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal
Jouni Hirvonen, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
Maria João Gomes
INEB—Instituto de Engenharia Biomédica, Universisdade do Porto, Porto, Portugal
ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
Instituto de Investigação e Inovação em Saude, Universidade do Porto, Porto, Portugal
Christian Kölln, Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Braunschweig, Germany
Bianca N. Lourenço
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Faculdade de Engenharia da Universidade do Porto (FEUP), Porto, Portugal
Alexandra Machado
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Raquel Madureira, CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Porto, Portugal
Victor Mangas Sanjuan, Universidad Miguel Hernández, San Juan de Alicante, Alicante, España
Sara Marques, CIBIO/InBIO-UP—Centro de Investigação em Biodiversidade e Recursos Genéticos, University of Porto, Campus Agrário, Vairão, Portugal
Susana Martins, University of Southern Denmark, Odense, Denmark
Bárbara Mendes
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
Instituto de Investigação e Inovação em Saude, Universidade do Porto, Porto, Portugal
José Augusto Guimarães Morais, iMed.UL, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Rute Nunes, INEB—Instituto de Engenharia Biomédica, University of Porto, Porto, Portugal
Maria Beatriz P.P. Oliveira, Requimte, Faculty of Pharmacy, University of Porto, Porto, Portugal
Paulo Paixão, iMed.UL, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Carla Pereira
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
FEUP—Faculdade de Engenharia da Universidade do Porto, Porto, Portugal
Manuela Pintado, CBQF—Centro de Biotecnologia e Química Fina—Laboratório Associado, Escola Superior de Biotecnologia, Universidade Católica Portuguesa/Porto, Porto, Portugal
Stephan Reichl, Institut für Pharmazeutische Technologie, Technische Universität Braunschweig, Braunschweig, Germany
Francisca Rodrigues
Requimte, Faculty of Pharmacy, University of Porto, Porto, Portugal
Fourmag Lda, Parque Industrial do Cruzeiro, Moreira de Cónegos, Portugal
Ellaine Salvador, Department of Anaesthesia and Critical Care, University of Wurzburg, Wurzburg, Germany
Hélder A. Santos, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
Bruno Sarmento
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Instituto Superior de Ciências da Saúde-Norte, Departamento de Ciências Farmacêuticas, Gandra-PRD, Portugal
Neha Shrestha, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
Cátia Silva, CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Gandra PRD, Portugal
Nuno Silva, iMed.UL, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Nataša Škalko-Basnet, University of Tromsø The Arctic University of Norway, Tromsø, Norway
Alejandro Sosnik, Technion-Israel Institute of Technology, Technion City, Haifa, Israel
Flávia Sousa, CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, Instituto Superior de Ciências da Saúde-Norte, Gandra PRD, Portugal
Ingunn Tho, University of Oslo, Oslo, Norway
Ana Vanessa Nascimento
University of Porto, Porto, Portugal
IINFACTS, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde, CESPU, Cooperativa...
Erscheint lt. Verlag | 30.9.2015 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Naturwissenschaften ► Biologie ► Zellbiologie | |
ISBN-10 | 0-08-100114-2 / 0081001142 |
ISBN-13 | 978-0-08-100114-1 / 9780081001141 |
Haben Sie eine Frage zum Produkt? |
Größe: 13,3 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
Größe: 11,8 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich